BNET Industries
Market Cap:$145.8B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Pfizer PFE and Crown Bio to Collaborate in Development of Novel Therapeutics for Asian Cancers
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Pfizer and B.C. launch $9M collaboration to tackle cancer
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
-
Protalix Completes NDA Submission for taliglucerase alfa for the Treatment of Gaucher s Disease
-
Pfizer Inc. PFE JOBS Acquires Rights to Protalix Biotherapeutics's Gaucher Drug in Deal Worth $115M
-
Conservationists salute two corporations
-
Pfizer PFE Will Not Renew Ethical Distribution Agreement Term with MWI Veterinary Supply MWIV
-
2009: The Year That Was For Pfizer
-
A 2nd Loss for Pfizer in Drug Suits
-
Pfizer acquires stem cell therapies assets of Axordia
-
Standpoint Raised Its FY10 Price Target on Pfizer PFE to $24
-
ImmunoVaccine signs exclusive licence deal with Pfizer
-
Pfizer Animal Health selects Bader Rutter as agency of record
News & Analysis
Filter by
marketing and pfizer inc. and pharmaceutical company - All News and Analysis
Pharma Roundup: AstraZeneca's Crestor Success, Pfizer's Chantix Problems, and More
BNET
- 2008-11-10
Highly encouraging results on AZ's Crestor, UK drug regulators echo Chantix suicide concerns, OTC drug marketers struggle, Lilly CEO highlights three "gorillas" dogging pharma. by John Maas
Pharma Roundup: Wyeth Slimming Distribution Network, Pfizer Suppressed Study, and More
BNET
- 2008-10-08
Wyeth eliminates East Coast distributor; Pfizer suppressed Neurontin study; entrepreneur urges rescue of U.K. biotech industry; pharma companies now contributing to McCain. by John Maas
DTC Marketing.(direct-to-consumer marketing by pharmaceutical manufacturers)(Brief Article)
- 2000-04-03
Direct-to-consumer drug advertising has entered its next evolutionary phase. The banal images of smiley, happy people in physician-targeted advertising later translated into consumer ads are out. Star power is in. Pharmaceutical companies are now tur Direct-to-consumer drug advertising has entered its next evolutionary phase. The...
To Your Health.(pharmaceutical industry marketing)
- 1998-09-07
00-00-0000 Reaping the benefits of new drug discovery, pharmaceutical companies are now flexing their marketing muscle. IN A RECENT SURVEY OF PHYSICIANS, 29% SAID THEY RECEIVED specific requests from patients for Schering- Plough Corp.'s Claritin, ma 00-00-0000 Reaping the benefits of new drug discovery,...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
Presented by the Premiere Rewards Gold Card from American Express